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(Many cytokines are known to play a role in host
defense against viral infections (Thomson, 1998). While
cytokines, such as interferon (IFN)-a/b, IFN-g, and tumor
necrosis factor (TNF)-a, have the potential to trigger the
ctivation of intracellular antiviral pathways after they
ind to specific receptors on the surface of the infected
ells, other cytokines, such as interleukin (IL)-1a, IL-1b,
IL-2, IL-6, IL-12, IL-13, and IL-18, are believed to contrib-
ute to the antiviral response indirectly, by modulating
various aspects of the immune response, including the
autocrine or paracrine upregulation of IFN-a/b, IFN-g,
nd TNF-a (Thomson, 1998). Most cell types in the body
espond to an incoming viral infection by secreting IFN-
a/b. Conversely, the production of IFN-g and TNF-a is
predominantly confined to cells of the immune system
[natural killer (NK) cells, natural killer T (NKT) cells, T
helper (TH) cells, cytotoxic T cells (CTL), macrophages,
and dendritic cells (DC)] (Thomson, 1998). Collectively,
these cytokines can inhibit the replication of many DNA
and RNA viruses and even purge susceptible viruses
from infected cells noncytopathically. In this review, we
summarize a series of studies that investigate the con-
tribution of cytokine-dependent, noncytolytic mecha-
nisms to viral clearance.
The induction of IFN-a/b by virus-infected cells occurs
ery rapidly (within a few hours of the infection) and
epresents the earliest antiviral response in the host
Thomson, 1998). Importantly, however, the early, virus-
nduced cytokine response may not be limited to IFN-
a/b. For example, certain viruses [such as HIV or lym-
hocytic choriomeningitis virus (LCMV)] have the poten-
ial to infect and rapidly activate macrophages to
roduce additional antiviral cytokines, such as TNF-a
(Guidotti et al., 1996a; Merrill and Chen, 1991), which can
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221trigger independent antiviral activities. Nonetheless, the
induction of IFN-a/b is widely accepted as the most
mmediate and important antiviral host response to many
iral infections (Thomson, 1998). It has been long known
hat IFN-a/b can inhibit the replication of many viruses in
itro (Thomson, 1998), including picornaviruses, retrovi-
uses, influenza viruses, vesicular stomatitis virus (VSV),
SV herpes simplex virus (HSV), vaccinia virus, adeno-
irus, reovirus, and others (Vilcek and Sen, 1996). More-
ver, many viruses [including vaccinia virus, VSV, LCMV,
emliki Forest virus, HSV, and hepatitis B virus (HBV)]
ave been shown to be sensitive to the antiviral activity
f IFN-a/b in vivo by demonstrating they replicate uncon-
trollably in mice either that received neutralizing antibod-
ies to IFN-a/b (Gresser, 1984; Moskophidis et al., 1994)
or that were genetically deficient for the IFN-a/b receptor
(Kamijo et al., 1994; Leib et al., 1999; McClary et al., 2000;
Muller et al., 1994) or IFN-b (Deonarain et al., 2000). In
ost of these in vivo studies, however, it is difficult to
etermine whether IFN-a/b is contributing to viral clear-
nce by direct antiviral or indirect immunoregulatory
echanisms. Only in the case of HBV was the direct
ntiviral effect of IFN-a/b demonstrable in vivo because
those studies were done in HBV transgenic mice that are
immunologically tolerant to the viral proteins (Guidotti et
al., 1995; Shimizu et al., 1998). Finally, it is important to
note that different viruses can be differentially sensitive
to IFN-a/b (Vilcek and Sen, 1996). This is true even for
ifferent strains of the same virus, as in the case of
epatitis C virus (HCV) (Enomoto et al., 1996), LCMV
Moskophidis et al., 1994) or reovirus (Samuel, 1998).
Based on these studies, it is clear that IFN-a/b and
other virus-induced cytokines can play a very important
role in controlling the replication of many viruses during
the initial phase of the infection. Clearance of viral infec-
tions, however, requires additional functions of the im-
mune response. The accepted dogma is that clearance
of intracellular viruses by the immune response depends
on the destruction of infected cells by major histocom-
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222 MINIREVIEWpatibility complex (MHC) class I-restricted, CD81 CTLs.
This notion, however, has been recently challenged by
experimental evidence showing that antiviral cytokines
secreted by CTLs (and potentially by other cells of the
immune system) can purge susceptible viruses from
cells that are not killed (Guidotti and Chisari, 1999) (see
below).
For 25 years after the Nobel Prize-winning discovery of
MHC-restriction (Zinkernagel and Doherty, 1974), the an-
tiviral function of the CTL response was studied by mon-
itoring the cytolytic activity of CTLs in vitro. This limited
approach, coupled with the exquisite specificity of the
CTL–MHC interaction (virus A-specific CTLs kill virus
A-infected, MHC-matched cells but not virus A-infected,
MHC-mismatched or virus B-infected cells) (Lukacher et
al., 1984), created the mistaken impression that viral
clearance by CTLs is due primarily to direct physical
contact and CTL-mediated killing of infected cells. This
notion was also supported by experimental evidence
showing that mice deficient for either CTLs or perforin
and/or Fas are unable to control certain viral infections,
including LCMV (Kagi et al., 1994; Walsh et al., 1994),
Theiler’s virus (Rossi et al., 1998), influenza (Topham et
al., 1997), and herpes simplex virus (HSV) (Holterman et
al., 1999). Experiments using hepatitis B virus (HBV)
transgenic mice (Guidotti and Chisari, 1999; Guidotti et
al., 1996b), however, demonstrated that, upon antigen
recognition, CTLs do not merely kill infected cells; they
also release antiviral cytokines that can purge suscepti-
ble viruses from hundreds or thousands of additional
FIG. 1. CTL killing is less efficient than CTL curing. Upon antigen rec
In addition, CTLs secrete antiviral cytokines that have the potential to
cells noncytopathically, suggesting that much of the antiviral potentialinfected cells noncytopathically. These results, schemat-
ically illustrated in Fig. 1, suggest that much of the anti-
t
Nviral potential of the CTL response relies upon noncyto-
lytic mechanisms.
The HBV transgenic mouse studies (Guidotti et al.,
1994, 1996b) were preceded by other experiments dem-
onstrating that IFN-g and TNF-a can affect the outcome
of viral infections. For example, it was shown that infec-
tion of normal or immunodeficient mice with vaccinia
virus expressing IFN-g or TNF-a leads to attenuation of
virus-induced pathogenicity and rapid viral clearance
(Karupiah et al., 1990; Kohonen-Corish et al., 1990; Ram-
haw et al., 1992; Sambhi et al., 1991) and that IFN-g and
NF-a also contribute to viral clearance during murine
ytomegalovirus (MCMV) infection in mice (Lucin et al.,
992; Pavic et al., 1993). Furthermore, it was reported that
ntibodies to IFN-g (but not to TNF-a) could partially
inhibit immune-mediated clearance of LCMV from in-
fected tissues following the adoptive transfer of immune
spleen cells (Klavinskis et al., 1989) and that LCMV was
not cleared when relatively high numbers of IFN-g-defi-
ient CTLs were passively transferred (Tishon et al.,
995). In addition, LCMV replication was shown to be
ess efficiently controlled in mice that lack the IFN-g
receptor (Muller et al., 1994) or that have been treated
with IFN-g-specific antibodies (Leist et al., 1989).
While all of these studies demonstrated a role for
FN-g and/or TNF-a in the control of viral infections, they
id not demonstrate that these cytokines directly inhib-
ted viral replication. Indeed, the antiviral effect could
ave been due to immunoregulatory activity of these
ytokines or by their ability to enhance antigen presen-
n, virus-specific CTLs trigger the death of infected cells by apoptosis.
usceptible viruses from hundreds or thousands of additional infected
CTL response relies upon noncytolytic mechanisms.ognitioation or to stimulate the cytolytic function of NK cells,
KT cells, or CTLs, thereby increasing their ability to kill
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223MINIREVIEWthe infected cells. Since the number of infected cells was
not demonstrated in these models, if they represented a
small fraction of the total cells in vital organs or a high
percentage of the cells in nonvital organs, the CTLs
could have easily destroyed the infected cells without
having a noticeable impact on the function of the infected
tissues or the survival of the host.
In contrast to these experiments, however, the direct
antiviral potential of CTL-derived cytokines was clearly
separated from their indirect immunoregulatory activity
in the HBV transgenic mouse model in a manner that
could not be done during a natural infection, where
viruses can reinfect potentially cured cells, thereby ob-
scuring the observations. Unlike natural infections, HBV
is not infectious for mice. In transgenic mice, HBV is
produced by each hepatocyte but it cannot spread from
cell to cell (Guidotti et al., 1995). Furthermore, the mice
are profoundly immunologically tolerant to the virus
(Guidotti et al., 1995; Shimizu et al., 1998). Thus, it was
possible in this model to demonstrate that the intrahe-
patic induction of cytokines (such as IFN-g) produced by
irus-specific CTLs and by nonspecific inflammatory
ells activated in the liver by other proinflammatory stim-
li was sufficient to completely inhibit HBV replication in
he liver, even under conditions where no killing of hepa-
ocytes was detectable (Guidotti et al., 1994, 1996a,b;
uidotti and Chisari, 1999; McClary et al., 2000).
Based on these observations, therefore, it is possible
hat cytokines produced by activated immune cells play
major role in viral clearance during HBV and other viral
nfections. Indeed, a recent study in acutely infected
himpanzees has confirmed that noncytopathic antiviral
echanisms contribute to HBV clearance in a natural
nfection model (Guidotti et al., 1999b). In that study, it
as shown that HBV DNA disappears from the liver of
cutely infected chimpanzees largely before the onset of
iver disease, concomitant with the intrahepatic appear-
nce of IFN-g (Guidotti et al., 1999b). Furthermore, the
appearance of this cytokine in the chimp liver precedes
the peak of T cell infiltration (Guidotti et al., 1999b),
suggesting that IFN-g might have been produced by
cells other than CTLs, including NK and NKT cells. Along
these lines, it has recently been shown that similar in-
terferon-dependent, noncytopathic antiviral activities are
also observed in HBV transgenic mice following specific
activation of the intrahepatic NKT cells (Kakimi et al.,
submitted). Finally, several reports in the past few years
have suggested that other viruses, including adenovirus
(Benihoud et al., 1998; McClary et al., 2000; Zhang et al.,
1998), mouse hepatitis virus (Lin et al., 1998; Parra et al.,
1999), coxsackievirus (Gebhard et al., 1998; Horwitz et
al., 1999), and measles virus (Parra et al., 1999), may be
susceptible to the antiviral activity of cytokines produced
by CTLs or other immune cells.
Two fundamental requirements are necessary for an-tiviral curative mechanisms to occur. First, the virus must
be sensitive to the cytokine-inducible intracellular mech-
anisms of viral inactivation. Second, the infected cell
must be able to activate such mechanisms.
Cytokines activate different intracellular antiviral
mechanisms that have the potential to target virtually
every step of the viral life cycle (Samuel, 1991; Stark et
al., 1998; Vilcek and Sen, 1996). For example, viral entry
of DNA viruses (such as SV40 and adenovirus) and RNA
viruses (such as retroviruses) has been shown to be
affected by IFN-a/b (Vilcek and Sen, 1996). Transcription,
translation, assembly, and secretion of a variety of addi-
tional DNA and RNA viruses can also be inhibited by
IFN-a/b or IFN-g (Stark et al., 1998; Vilcek and Sen, 1996).
A large variety of IFN-inducible genes have been iden-
ified to date, most of which are activated by the JAK-
TAT signal transduction cascade (Kalvakolanu and Bor-
en, 1996). The recent advent of oligonucleotide arrays
as enabled investigators to begin to identify many novel
FN-inducible or IFN-repressed genes (Der et al., 1998;
hu et al., 1997). However, it is still poorly understood
ow most of these genes exert their intracellular antiviral
ctivities. Among the IFN-inducible genes, the 2959-oli-
oadenylate synthetases, the Mx proteins, and the dou-
le-stranded RNA-activated protein kinase (PKR) sys-
ems are the best characterized. The 2959-oligoadenylate
ystem mediates antiviral activities mainly by the induc-
ion of RNAse L, a cellular RNAse that degrades viral
ranscripts (Dong and Silverman, 1999; Silverman, 1994;
erenzi et al., 1999). This pathway has been shown to
electively reduce the intracellular RNA content of vi-
uses such as HIV, encephalomyocarditis virus, and vac-
inia virus (Diaz-Guerra et al., 1997; Li et al., 1998; Maitra
nd Silverman, 1998). The MxA protein is an interferon-
nduced GTPase that selectively inhibits influenza and
unyaviruses (Haller et al., 1998), probably via direct
inding to viral ribonucleoprotein complexes (Kochs and
aller, 1999). Furthermore, recent studies have shown
hat Thoghoto virus nuclear import can be affected by the
xA protein (Kochs and Haller, 1999). The inhibition of
iral protein synthesis initiation by the IFN-inducible PKR
as been reported to suppress certain viral infections,
ncluding encephalomyocarditis virus and reovirus (Kal-
akolanu and Borden, 1996; Samuel, 1998). Recently, the
nteraction between the HCV protein E2 and PKR has
een suggested to reduce the sensitivity of this virus to
FN-a/b (Taylor et al., 1999).
Recent experiments have shown that two independent
antiviral events are activated by IFNs in the hepatocytes
of HBV transgenic mice. The first event is the IFN-depen-
dent inhibition of formation and/or destabilization of im-
mature RNA-containing capsids (Wieland et al., 2000).
The second event is the degradation of preformed viral
RNA in the nucleus of the hepatocyte (Tsui et al., 1995).
Recent studies have demonstrated that HBV mRNA sta-
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224 MINIREVIEWbility is associated with the presence of a 45-kDa nuclear
ribonucleoprotein (SSB/La) (Heise et al., 1999) that binds
predicted stem–loop structure in the viral RNA (Heise
t al., 1999). Interferon appears to trigger the cleavage of
SB/La, thereby exposing an endoribonuclease sensi-
ive site in the viral RNA resulting in its degradation
Heise et al., submitted). Thus, the interaction between
he SSB/La protein and the stem–loop may contribute to
BV RNA stability under baseline conditions and the
ytokine-induced cleavage of SSB/La may facilitate the
estabilization of viral RNA by exposing previously pro-
ected sequences to nuclear endoribonuclease activities
hat may themselves be induced by cytokines.
Additional, undefined intracellular antiviral pathways
re induced by IFN-a/b (Zhou et al., 1999) and very little
s known on the mechanisms activated by other cyto-
ines, including TNF-a. It is also important to note that
cytokines can activate cells to produce downstream me-
diators, including nitric oxide, that have been shown to
exert antiviral activities toward a variety of viruses (Reiss
and Komatsu, 1998), including HBV. Indeed, it has been
recently shown in the HBV transgenic mouse model that
NO mediates most of the antiviral activity of IFN-g pro-
duced by the CTLs (Guidotti et al., 2000). A mechanism
whereby NO may impair viral replication has been re-
cently reported. In that study, it was shown that the
antiviral activity of NO targets a viral protease from cox-
sackievirus (Saura et al., 1999).
As mentioned above, another requirement for cyto-
kine-induced virus purging is that the intracellular anti-
viral mechanisms described above must be operative in
the infected cell. Indeed, it is possible that such mech-
anisms may not operate in all cell types. If this is correct,
one would expect that the same virus could be controlled
by the immune system by either curative or cytodestruc-
tive mechanisms, depending upon the cell in which it
replicates. Indeed, as illustrated in Fig. 2, this is the case
FIG. 2. Some cells are curable, others are not. Cytokine-induced
antiviral mechanisms may not operate in all cell types. Thus, the same
virus could be controlled by the immune system by either curative or
cytodestructive mechanisms, depending upon the cell in which it rep-
licates.for LCMV as well as certain other viruses, including
MCMV and vaccinia virus. Recent studies have shown
k
cthat LCMV can be eliminated from the hepatocytes in a
cytokine-dependent, noncytopathic bystander manner. A
similar mechanism has been proposed to explain the
clearance of LCMV from infected neurons (Oldstone et
al., 1986; Tishon et al., 1993). In contrast, other events,
presumably killing, are needed to eliminate LCMV from
nonparenchymal cells of the liver and from the spleen
(Guidotti et al., 1999a). Furthermore, it has been shown
hat control of murine cytomegalovirus infection in the
iver and vaccinia virus in the central nervous system
rimarily depends on IFN-dependent noncytopathic
echanisms, while cytopathic events probably contrib-
te to the clearance of these viruses from other organs
Kundig et al., 1993; Tay and Welsh, 1997). These obser-
ations suggest that the relative sensitivity of viruses to
urative mechanisms may depend on the capacity of the
nfected cell to produce the appropriate intracellular an-
iviral factors. This may be particularly important for vi-
uses that infect a large number of parenchymal cells in
ital organs, like the liver or the brain.
In keeping with the concept of intracellular viral inac-
ivation, a number of viruses encode proteins that have
he potential to inhibit the antiviral activity of interferons
nd other cytokines. Several comprehensive reviews
ave been written on this subject in the past 3 years
Estcourt et al., 1998; Herbein and O’Brien, 2000; Kalva-
olanu, 1999; Nash et al., 1999; Ploegh, 1998; Wall et al.,
998). Interestingly, two basic strategies are usually em-
loyed. The first is due to the ability of virus proteins to
nterfere with cytokine-induced signaling or with the an-
iviral activities of cytokine-induced genes intracellularly,
.g., the inhibition of the function of ISGF3 (a cellular
ranscription factor induced by IFN-a/b) by the E1A pro-
tein of adenovirus (Reich et al., 1988). The second is due
to the ability of certain viral proteins to interfere with the
antiviral activities of cytokines extracellularly, e.g., as
cytokine antagonists or receptor analogues (Herbein and
O’Brien, 2000; McFadden et al., 1998), as is well known
for viral proteins of various members of the poxvirus,
herpesvirus, and retrovirus families (McFadden et al.,
1998).
The cytokine-mediated, noncytopathic antiviral mech-
anisms described herein may represent an important
host survival strategy to control viral infections, espe-
cially when vital organs are massively infected. The cy-
tokine-mediated inhibition of viral replication may also
represent a strategy that viruses have evolved to reduce
their visibility and, therefore, promote viral persistence
by escaping immune recognition. In support of this no-
tion, it is important to mention that complete viral clear-
ance (viral sterilization) never occurs after infection with
viruses like HBV (Michalak et al., 1994; Rehermann et al.,
996) or LCMV (Ciurea et al., 1999), both of which are
nown to be susceptible to cytokine-mediated antiviral
ontrol (Guidotti et al., 1996b, 1999a; McClary et al.,
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225MINIREVIEW2000). Not only will future studies to define cytokine-
induced intracellular molecular events that control viral
infections improve our understanding of the host–virus
interactions that determine the outcome of infection, but
they may also lead to the discovery of new approaches
for the treatment of persistent viruses such as HBV, HCV,
and HIV.
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